© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
5 Ways AI Is Outperforming Experts
Innovation
07/03/20225 Ways AI Is Outperforming Experts

With DeepMind claiming that its AI system – AlphaCode – can “write computer code at a competitive level,” a milestone may have been reached. The ability of a machine to match the coding skills typical of human intelligence, if true, represents a moment

Read Full PostRead - Eye Icon
Boosting Business Efficiency: Innovative Solutions for Accurate Documentation and Record-Keeping
News
04/01/2024Boosting Business Efficiency: Innovative Solutions for Accurate Documentation and Record-Keeping

In today’s fast-paced business environment, efficiency is the key to success. One area where efficiency plays a crucial role is in documentation and record-keeping. Accurate and timely documentation not only ensures compliance with regulations but also e

Read Full PostRead - Eye Icon
India’s Internet of Things (IoT) Market to Grow
Strategy
25/09/2015India’s Internet of Things (IoT) Market to Grow

According to a recently released TechSci Research report, “India Internet of Things (IoT) Market Opportunities & Forecast, 2020”, the IoT market in India is projected to grow at a CAGR more than 28% during 2015 - 2020.

Read Full PostRead - Eye Icon
Where Next for Euro Government Bonds?
Finance
20/02/2015Where Next for Euro Government Bonds?

The ECB published its first-ever minutes of a policy meeting, revealing plans to expand its Quantitative Easing (QE) programme.

Read Full PostRead - Eye Icon
Preserving a Heritage of Excellence
Innovation
23/05/2018Preserving a Heritage of Excellence

Proserv is a global leader with a worldwide presence, offering a fresh alternative in the delivery of engineering and technical services to the energy, process and utility markets.

Read Full PostRead - Eye Icon
Budget 2015: Pennies Welcome – Pounds Preferred
Finance
19/03/2015Budget 2015: Pennies Welcome – Pounds Preferred

David McCorquodale, KPMG head of retail, comments on the impact of today's budget announcements on the UK High Street.

Read Full PostRead - Eye Icon
Warburg-HIH Invest Acquires Office Property in Poland
Finance
13/07/2016Warburg-HIH Invest Acquires Office Property in Poland

Warburg-HIH Invest Real Estate (Warburg-HIH Invest) just acquired an office scheme located at Aleja Pokoju 5 in the Polish city of Krakow within the framework of an individual mandate for an institutional investor.

Read Full PostRead - Eye Icon
Tangiers Group Acquires Osprey
Finance
08/04/2015Tangiers Group Acquires Osprey

Tangiers Group Acquires Osprey

Read Full PostRead - Eye Icon
Insuring Longevity Risk
Finance
01/11/2016Insuring Longevity Risk

Founded in 1978 by David Orford, Financial Synergy began life as an actuarial firm in Albert Rd, South Melbourne.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow